ProShare Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.8K | Sell |
|
|||||
|
2025
Q1 | $19K | Sell |
|
|||||
|
2024
Q4 | $36.5K | Buy |
|
|||||
|
2024
Q3 | $67.6K | Buy |
|
|||||
|
2024
Q2 | $58.3K | Buy |
|
|||||
|
2024
Q1 | $81K | Buy |
|
|||||
|
2023
Q4 | $47.4K | Buy |
|
|||||
|
2023
Q3 | $30.6K | Buy |
|
|||||
|
2023
Q2 | $55.7K | Buy |
|
|||||
|
2023
Q1 | $55.6K | Sell |
|
|||||
|
2022
Q4 | $50.3K | Buy |
|
|||||
|
2022
Q3 | $59K | Buy |
|
|||||
|
2022
Q2 | $37K | Sell |
|
|||||
|
2022
Q1 | $60K | Sell |
|
|||||
|
2021
Q4 | $143K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $81K | Buy |
|
|||||
|
2021
Q1 | $78K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $32K | Sell |
|
|||||
|
2020
Q2 | $45K | Buy |
|
|||||
|
2020
Q1 | $33K | Sell |
|
|||||
|
2019
Q4 | $119K | Sell |
|
|||||
|
2019
Q3 | $101K | Sell |
|
|||||
|
2019
Q2 | $224K | Sell |
|
|||||
|
2019
Q1 | $226K | Buy |
|
|||||
|
2018
Q4 | $269K | Sell |
|
|||||
|
2018
Q3 | $517K | Sell |
|
|||||
|
2018
Q2 | $602K | Sell |
|
|||||
|
2018
Q1 | $466K | Sell |
|
|||||
|
2017
Q4 | $625K | Buy |
|
|||||
|
2017
Q3 | $767K | Buy |
|
|||||
|
2017
Q2 | $951K | Sell |
|
|||||
|
2017
Q1 | $866K | Sell |
|
|||||
|
2016
Q4 | $1.04M | Buy |
|
|||||
|
2016
Q3 | $1.28M | Sell |
|
|||||
|
2016
Q2 | $1.18M | Buy |
|
|||||
|
2016
Q1 | $977K | Sell |
|
|||||
|
2015
Q4 | $1.19M | Buy |
|
|||||
|
2015
Q3 | $891K | Sell |
|
|||||
|
2015
Q2 | $709K | Sell |
|
|||||
|
2015
Q1 | $597K | Buy |
|
|||||
|
2014
Q4 | $359K | Buy |
|
|||||
|
2014
Q3 | $502K | Sell |
|
|||||
|
2014
Q2 | $682K | Sell |
|
|||||
|
2014
Q1 | $1.08M | Buy |
|
|||||
|
2013
Q4 | $436K | Sell |
|
|||||
|
2013
Q3 | $768K | Buy |
|
|||||
|
2013
Q2 | $509K | Buy |
|